88 related articles for article (PubMed ID: 3369870)
1. [Effect of MX-2, a morpholino anthracycline derivative, against human and rat glioma cells and experimental leptomeningeal tumors in rats].
Izumoto S; Arita N; Ushio Y; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Oku Y; Mogami H; Komeshima N
Gan To Kagaku Ryoho; 1988 May; 15(5):1765-9. PubMed ID: 3369870
[TBL] [Abstract][Full Text] [Related]
2. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
[TBL] [Abstract][Full Text] [Related]
3. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and antitumor activity of MX2, a new morpholino anthracycline in brain tumor intracerebral transplanted in rats].
Kiya K; Ogasawara H; Fujita H; Sugiyama K; Kurisu K; Kawamoto K; Uozumi T; Shinkai H
Gan To Kagaku Ryoho; 1993 Apr; 20(5):631-5. PubMed ID: 8470921
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of a new anthracycline derivative, MX2, against human glioma cells].
Kuratsu J; Mihara Y; Kochi M; Takaki S; Ushio Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):399-403. PubMed ID: 2930204
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the cytotoxicity of the morpholino anthracycline MX2 against glioma cells in vitro.
Park SJ; Kaye AH; Hill JS
J Clin Neurosci; 2000 Jan; 7(1):42-7. PubMed ID: 10847650
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor effect of MX2, a new morpholino anthracycline against C6 glioma cells and its combination effect with photodynamic therapy in vitro].
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Kitai R; Uno H; Kodera T
No To Shinkei; 1995 Oct; 47(10):969-73. PubMed ID: 7577142
[TBL] [Abstract][Full Text] [Related]
8. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
Watanabe M; Komeshima N; Nakajima S; Tsuruo T
Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
10. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
11. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
[TBL] [Abstract][Full Text] [Related]
13. [Meningeal gliomatosis model in nude mice].
Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Yoshida T; Hayakawa T; Tsuda N; Mogami H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2600-5. PubMed ID: 3740860
[TBL] [Abstract][Full Text] [Related]
14. Flk-1 specific kinase inhibitor (SU5416) inhibited the growth of GS-9L glioma in rat brain and prolonged the survival.
Takamoto T; Sasaki M; Kuno T; Tamaki N
Kobe J Med Sci; 2001 Aug; 47(4):181-91. PubMed ID: 11733657
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of MX2, a new morpholino anthracycline, in CSF following intravenous injection].
Yamamoto H; Arita N; Ohnishi T; Hiraga S; Izumoto S; Taki T; Higuchi M; Hayakawa T; Shinkai H
Gan To Kagaku Ryoho; 1993 Jul; 20(9):1227-30. PubMed ID: 8333749
[TBL] [Abstract][Full Text] [Related]
16. [Meningeal gliomatosis: development of experimental models].
Yoshida T; Ushio Y; Hayakawa T; Arita N; Yamada K; Mogami H
No Shinkei Geka; 1984 Sep; 12(10):1141-8. PubMed ID: 6504251
[TBL] [Abstract][Full Text] [Related]
17. [Meningeal gliomatosis models as a chemosensitivity assay system].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect and peritumoral brain edema formation in relation to MX2, ACNU, and doxorubicin therapy: a comparative analysis using rodent models of gliomas.
Mima T; Mostafa MG; Mori K
Neurol Res; 2000 Dec; 22(8):819-24. PubMed ID: 11149245
[TBL] [Abstract][Full Text] [Related]
20. [Anti-tumor effect of hyperthermia plus hematoporphyrin derivative on malignant brain tumor].
Hondo H
No To Shinkei; 1988 May; 40(5):477-84. PubMed ID: 3415865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
